Vanguard Fiduciary Trust’s Genelux GNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$711K Sell
236,344
-15,266
-6% -$43.2K ﹤0.01% 3150
2026
Q1
$609K Buy
+251,610
New +$686K ﹤0.01% 3152

Other funds holding GNLX

Vanguard Fiduciary Trust's GNLX Position: Q2 2026 in Review

Vanguard Fiduciary Trust reduced its Genelux (GNLX) stake by 6.1% in Q2 2026, selling an estimated $43.2K and leaving 236,344 shares worth $711K. The position accounts for ﹤0.01% of the portfolio, ranked #3150.

Vanguard Fiduciary Trust first reported a position in GNLX in Q1 2026 and has held it in 2 quarters since. 73 funds tracked by Wall St. Rank hold GNLX as of Q2 2026.

  • Vanguard Fiduciary Trust held 236,344 shares of Genelux worth $711K as of Q2 2026.
  • Vanguard Fiduciary Trust sold 15,266 Genelux shares in Q2 2026, an estimated $43.2K.
  • Genelux made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3150 holding.
  • Vanguard Fiduciary Trust first reported a position in Genelux in Q1 2026 and has held it in 2 quarters since.
  • 73 funds tracked by Wall St. Rank held Genelux as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.